Therapeutic administration of the chemokine CXCL1/KC abrogates autoimmune inflammatory heart disease

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Bachmaier, Kurt ^a   Toya, Sophie ^a   Malik, Asrar B ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CXCL1 CHEMOKINE; INTERLEUKIN 6; MESSENGER RNA; RECOMBINANT PROTEIN; TOLL LIKE RECEPTOR 4;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; CD4+ T LYMPHOCYTE; CELL DAMAGE; CELL EXPANSION; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; EXPERIMENTAL AUTOIMMUNE MYOCARDITIS; FEMALE; HEART MUSCLE CELL; HISTOPATHOLOGY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; MOLECULAR DYNAMICS; MOUSE; MYOCARDITIS; NONHUMAN; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION;

ANIMALS; AUTOIMMUNE DISEASES; B-LYMPHOCYTES; CHEMOKINE CXCL1; DISEASE MODELS, ANIMAL; FEMALE; LIGANDS; MICE; MICE, KNOCKOUT; MODELS, BIOLOGICAL; MYOCARDITIS; MYOSIN HEAVY CHAINS; NITRIC OXIDE SYNTHASE TYPE II; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TOLL-LIKE RECEPTOR 4;

EID: 84897901492     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0089647     Document Type: Article

References (51)

1. Baughman KL (2006) Diagnosis of Myocarditis. Circulation 113: 593-595.
2. Cooper LT (2009) Medical Progress: Myocarditis. New England Journal Of Medicine 360: 1526-1538.
3. Magnani JW, Dec GW (2006) Myocarditis: current trends in diagnosis and treatment. Circulation 113: 876-890.
4. Cunningham MW (2009) Turning Point in Myocarditis. Circulation Research 105: 403-405.
5. Grogan M, Redfield MM, Bailey KR, Reeder GS, Gersh BJ, et al. (1995) Long-term outcome of patients with biopsy-proved myocarditis: comparison with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 26: 80-84.
6. Bachmaier K, Neu N, de la Maza LM, Pal S, Hessel A, et al. (1999) Chlamydia infections and heart disease linked through antigenic mimicry. Science 283: 1335-1339.
7. Donermeyer DL, Beisel KW, Allen PM, Smith SC (1995) Myocarditis-Inducing Epitope Of Myosin Binds Constitutively And Stably To I-A(K) On Antigen-Presenting Cells In The Heart. Journal Of Experimental Medicine 182: 1291-1300.
8. Blander JM, Medzhitov R (2006) Toll-dependent selection of microbial antigens for presentation by dendritic cells. Nature 440: 808-812.
9. Valaperti A, Marty RR, Kania G, Germano D, Mauermann N, et al. (2008) CD11b(+) monocytes abrogate th17 CD4(+) T cell-mediated experimental autoimmune myocarditis. Journal Of Immunology 180: 2686-2695.
10. Baldeviano GC, Barin JG, Talor MV, Srinivasan S, Bedja D, et al. (2010) Interleukin-17A is dispensable for myocarditis but essential for the progression to dilated cardiomyopathy. Circ Res 106: 1646-1655.
11. Nishikubo K, Imanaka-Yoshida K, Tamaki S, Hiroe M, Yoshida T, et al. (2007) Th1-type immune responses by Toll-like receptor 4 signaling are required for the development of myocarditis in mice with BCG-induced myocarditis. J Autoimmun 29: 146-153. (Pubitemid 47385115)
12. Roberts BJ, Moussawi M, Huber SA (2013) Sex differences in TLR2 and TLR4 expression and their effect on coxsackievirus-induced autoimmune myocarditis. Exp Mol Pathol 94: 58-64.
13. Fairweather D, Yusung S, Frisancho S, Barrett M, Gatewood S, et al. (2003) IL-12 receptor beta 1 and Toll-like receptor 4 increase IL-1 beta- and IL-18-associated myocarditis and Coxsackievirus replication. Journal Of Immunology 170: 4731-4737. (Pubitemid 36519981)
14. Yamashita T, Iwakura T, Matsui K, Kawaguchi H, Obana M, et al. (2011) IL-6-mediated Th17 differentiation through ROR gamma t is essential for the initiation of experimental autoimmune myocarditis. Cardiovascular Research 91: 640-648.
15. Rangachari M, Mauermann N, Marty RR, Dirnhofer S, Kurrer MO, et al. (2006) T-bet negatively regulates autoimmune myocarditis by suppressing local production of interleukin 17. Journal Of Experimental Medicine 203: 2009-2019. (Pubitemid 44188474)
16. Marty RR, Dirnhofer S, Mauermann N, Schweikert S, Akira S, et al. (2006) MyD88 signaling controls autoimmune myocarditis induction. Circulation 113: 258-265.
17. Poltorak A, He XL, Smirnova I, Liu MY, Van Huffel C, et al. (1998) Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: Mutations in Tlr4 gene. Science 282: 2085-2088. (Pubitemid 29001265)
18. Su SB, Silver PB, Grajewski RS, Agarwal RK, Tang J, et al. (2005) Essential role of the MyD88 pathway, but nonessential roles of TLRs 2, 4, and 9, in the adjuvant effect promoting Th1-mediated autoimmunity. Journal Of Immunology 175: 6303-6310. (Pubitemid 41598869)
19. Krieg AM, Vollmer J (2007) Toll-like receptors 7, 8, and 9: linking innate immunity to autoimmunity. Immunological Reviews 220: 251-269. (Pubitemid 350045572)
20. Bachmaier K, Mair J, Offner F, Pummerer C, Neu N (1995) Serum Cardiac Troponin-T and Creatine Kinase-Mb Elevations in Murine Autoimmune Myocarditis. Circulation 92: 1927-1932.
21. Somerville JE, Cassiano L, Bainbridge B, Cunningham MD, Darveau RP (1996) A novel Escherichia coli lipid a mutant that produces an antiinflammatory lipopolysaccharide. Journal Of Clinical Investigation 97: 359-365. (Pubitemid 26039398)
22. Coats SR, Reife RA, Bainbridge BW, Pham TTT, Darveau RP (2003) Porphyromonas gingivalis lipopolysaccharide antagonizes Escherichia coli lipopolysaccharide at toll-like receptor 4 in human endothelial cells. Infection And Immunity 71: 6799-6807. (Pubitemid 37475308)
23. Ono M, Shimizu J, Miyachi Y, Sakaguchi S (2006) Control of autoimmune myocarditis and multiorgan inflammation by glucocorticoid-induced TNF receptor family-related protein high, Foxp3-expressing CD25(+) and CD25(-) regulatory T cells. Journal Of Immunology 176: 4748-4756.
24. Caramalho I, Lopes-Carvalho T, Ostler D, Zelenay S, Haury M, et al. (2003) Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharide. Journal Of Experimental Medicine 197: 403-411. (Pubitemid 36278597)
25. Pasare C, Medzhitov R (2003) Toll pathway-dependent blockade of CD4(+)CD25(+) T cell-mediated suppression by dendritic cells. Science 299: 1033-1036. (Pubitemid 36222922)
26. Bachmaier K, Pummerer C, Kozieradzki I, Pfeffer K, Mak TW, et al. (1997) Low-molecular-weight tumor necrosis factor receptor p55 controls induction of autoimmune heart disease. Circulation 95: 655-661. (Pubitemid 27063043)
27. Eriksson U, Kurrer MO, Schmitz N, Marsch SC, Fontana A, et al. (2003) Interleukin-6-deficient mice resist development of autoimmune myocarditis associated with impaired upregulation of complement C3. Circulation 107: 320-325. (Pubitemid 36135231)
28. Witowski J, Pawlaczyk K, Breborowicz A, Scheuren A, Kuzlan-Pawlaczyk M, et al. (2000) IL-17 stimulates intraperitoneal neutrophil infiltration through the release of GRO alpha chemokine from mesothelial cells. Journal of Immunology 165: 5814-5821.
29. Sun DX, Novotny M, Bulek K, Liu CN, Li XX, et al. (2011) Treatment with IL-17 prolongs the half-life of chemokine CXCL1 mRNA via the adaptor TRAF5 and the splicing-regulatory factor SF2 (ASF). Nature Immunology 12: 853-U870.
30. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R (2004) Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 118: 229-241. (Pubitemid 38962578)
31. Tarabishy AB, Aldabagh B, Sun Y, Imamura Y, Mukherjee PK, et al. (2008) MyD88 regulation of Fusarium keratitis is dependent on TLR4 and IL-1R1 but not TLR2. Journal of Immunology 181: 593-600.
32. Ramos CDL, Canetti C, Souto JT, Silva JS, Hogaboam CM, et al. (2005) MIP-1 alpha-[CCL3] acting on the CCR1 receptor mediates neutrophil migration in immune inflammation via sequential release of TNF-alpha and LTB4. Journal Of Leukocyte Biology 78: 167-177. (Pubitemid 40979955)
33. Murray PJ, Wynn TA (2011) Protective and pathogenic functions of macrophage subsets. Nature Reviews Immunology 11: 723-737.
34. Bachmaier K, Neu N, Pummerer C, Duncan GS, Mak TW, et al. (1997) iNOS expression and nitrotyrosine formation in the myocardium in response to inflammation is controlled by the interferon regulatory transcription factor 1. Circulation 96: 585-591. (Pubitemid 27329438)
35. Correale J, Farez MF (2011) The impact of environmental infections (parasites) on MS activity. Multiple Sclerosis Journal 17: 1162-1169.
36. Kalliomaki M, Salminen S, Arvilommi H, Kero P, Koskinen P, et al. (2001) Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 357: 1076-1079. (Pubitemid 32322538)
37. Hizo-Abes P, Clark WF, Sontrop JM, Young A, Huang A, et al. (2012) Cardiovascular disease after Escherichia coli O157:H7 gastroenteritis. Canadian Medical Association Journal.
38. Fan XD, Patera AC, Pong-Kennedy A, Deno G, Gonsiorek W, et al. (2007) Murine CXCR1 is a functional receptor for GCP-2/CXCL6 and interleukin-8/CXCL8. Journal of Biological Chemistry 282: 11658-11666. (Pubitemid 47100704)
39. Damas JK, Eiken HG, Oie E, Bjerkeli V, Yndestad A, et al. (2000) Myocardial expression of CC- and CXC-chemokines and their receptors in human end-stage heart failure. Cardiovascular Research 47: 778-787.
40. Sakaguchi S (2005) Naturally arising Foxp3-expressing CD25(+) CD4(+) regulatory T cells in immunological tolerance to self and non-self. Nature Immunology 6: 345-352.
41. Pasare C, Medzhitov R (2004) Toll-dependent control mechanisms of CD4 T cell activation. Immunity 21: 733-741. (Pubitemid 39487894)
42. Kawai T, Akira S (2010) The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 11: 373-384.
43. Wittebole X, Castanares-Zapatero D, Laterre PF (2010) Toll-like receptor 4 modulation as a strategy to treat sepsis. Mediators Inflamm 2010: 568396.
44. Eriksson U, Ricci R, Hunziker L, Kurrer MO, Oudit GY, et al. (2003) Dendritic cell-induced autoimmune heart failure requires cooperation between adaptive and innate immunity. Nature Medicine 9: 1484-1490. (Pubitemid 38004775)
45. Eriksson U, Kurrer MO, Sebald W, Brombacher F, Kopf M (2001) Dual role of the IL-12/IFN-gamma axis in the development of autoimmune myocarditis: Induction by IL-12 and protection by IFN-gamma. Journal Of Immunology 167: 5464-5469. (Pubitemid 33009788)
46. Afanasyeva M, Wang Y, Kaya Z, Stafford EA, Dohmen KM, et al. (2001) Interleukin-12 receptor/STAT4 signaling is required for the development of autoimmune myocarditis in mice by an interferon-gamma-independent pathway. Circulation 104: 3145-3151. (Pubitemid 34014072)
47. Afanasyeva M, Wang Y, Kaya Z, Park S, Zilliox MJ, et al. (2001) Experimental autoimmune myocarditis in A/J mice is an interleukin-4-dependent disease with a Th2 phenotype. Am J Pathol 159: 193-203. (Pubitemid 33704204)
48. Riad A, Meyer Zu Schwabedissen H, Weitmann K, Herda LR, Dorr M, et al. (2012) Variants of Toll-like Receptor 4 Predict Cardiac Recovery in Patients with Dilated Cardiomyopathy. J Biol Chem 287: 27236-27243.
49. De Filippo K, Henderson RB, Laschinger M, Hogg N (2008) Neutrophil chemokines KC and macrophage-inflammatory protein-2 are newly synthesized by tissue macrophages using distinct TLR signaling pathways. Journal Of Immunology 180: 4308-4315.
50. Vogel SN, Wax JS, Perera PY, Padlan C, Potter M, et al. (1994) Construction Of A Balb/C Congenic Mouse, C.C3h-Lps(D), That Expresses The Lps(D) Allele - Analysis Of Chromosome-4 Markers Surrounding The Lps Gene. Infection And Immunity 62: 4454-4459. (Pubitemid 24301977)
51. Bachmaier K, Krawczyk C, Kozieradzki I, Kong YY, Sasaki T, et al. (2000) Negative regulation of lymphocyte activation and autoimmunity by the molecular adaptor Cbl-b. Nature 403: 211-216. (Pubitemid 30050966)